Collaborative Drug Discovery to Integrate Lilly TuneLab into CDD Vault

May 22, 2026
Collaborative Drug Discovery has announced a partnership with Eli Lilly and Company to integrate the Lilly TuneLab AI and machine learning drug discovery models into its CDD Vault platform, enabling biotech users to access Lilly’s predictive tools within their workflows.

Collaborative Drug Discovery has partnered with Eli Lilly and Company to integrate Lilly TuneLab, an AI and machine learning drug discovery platform, into CDD Vault. The collaboration was announced in a press release.

Lilly TuneLab was developed to accelerate biotechnology innovation by giving participating companies access to models trained on decades of Lilly’s proprietary research data. Through this integration, biotech companies using CDD Vault will be able to use select Lilly predictive models within their standard research workflows.

The agreement includes plans to integrate TuneLab within both the core and AI modules of CDD Vault for participating biotech companies. This partnership continues CDD’s focus on supporting web based collaboration in pharmaceutical research.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

05/22
Paragon Health Institute Proposes Framework to Address AI Medical Device Safety
05/22
Caris Life Sciences to Present 32 Precision Oncology Studies at ASCO 2026
05/22
Leo Cancer Care Receives CE Mark for Upright Radiotherapy System Marie
05/22
Verana Health Expands Real World Data Bladder Cancer Database
05/22
Helix and St. Luke’s Launch Genomic Program to Lower Healthcare Costs

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You May Also Like